Not only do CD36−/− HSCs possess full regenerative potential, CD36−/− HSCs also produce a balanced myeloid-lymphoid graft, indicating that CD36-driven FFA uptake in HSCs is a specific response to LPS and bacterial infection [12]. Here, CD36 is linked to bacterial infectious disease.